SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 3, 2003.
Commission File Number 000-23386
CRYO-CELL INTERNATIONAL, INC.
----------------------------------------------
(Name of Small Business Issuer in its charter)
DELAWARE 22-3023093
---------------------------- ----------------------
(State or other jurisdiction (I.R.S. Employer
of incorporation or Identification No.)
organization)
3165 McMullen Booth Road, Building B, Clearwater, FL 33761
------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Issuer's phone number, including area code: (727) 450-8000
-----------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events
Director Changes
The Board of Directors of the Company accepted the resignation of
Ronald B. Richard as a Director effective December 31, 2002. Mr. Richard
currently remains as Chief Executive Officer and Director of Stem Cell
Preservation Technologies, Inc.
The Board of Directors of the Company's subsidiary Stem Cell
Preservation Technologies, Inc. accepted the resignation of Mercedes Walton as a
Director of the subsidiary effective December 31, 2002. Ms. Walton currently
remains as Chairman of the Board of the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
CRYO-CELL INTERNATIONAL, INC.
Date: January 3, 2003 By: /s/ John V. Hargiss
----------------------------
John V. Hargiss
Chief Executive Officer